Literature DB >> 30815956

Letter on 'Idarucizumab for the reversal of dabigatran in patients undergoing heart transplantation'.

Eran Kalmanovich1, Philippe Gaudard2, François Roubille1,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30815956     DOI: 10.1002/ejhf.1446

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  1 in total

1.  Idarucizumab (Praxbind®) for dabigatran reversal in patients undergoing heart transplantation: a cohort of ten patients.

Authors:  Eran Kalmanovich; Pascal Battistella; Philippe Rouviere; Bernard Albat; Jean-Marc Frapier; Roland Demaria; Fabien Huet; Audrey Agullo; Marc Mourad; Pascal Colson; Florence Leclercq; Philippe Gaudard; François Roubille
Journal:  Future Sci OA       Date:  2021-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.